In conclusion, our study provided robust evidence that miR-486-5p acted as a tumor-suppressor gene to inhibit CRC cells' proliferation and migration through regulating PLAGL2/IGF2/β-catenin expression and served as a novel prognostic and diagnostic biomarker of CRC. Here, IGF2 is linked to neoplasm.